Literature DB >> 30523483

How Dye May Prevent Dying from Cancer: Perceiving Imperceptible Dysplasia in Inflammatory Bowel Disease.

Sara M Lewin1, Kwun Wah Wen2, Fernando S Velayos3, Uma Mahadevan1, Kendall R Beck4.   

Abstract

Entities:  

Keywords:  Chromoendoscopy; High-grade dysplasia of the colon; Inflammatory bowel disease; Intramucosal adenocarcinoma; Low-grade dysplasia of the colon

Mesh：

Substances：

Year:  2019        PMID： 30523483     DOI： 10.1007/s10620-018-5409-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  9 in total

Review 1.  The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002.

Authors: 
Journal:  Gastrointest Endosc       Date:  2003-12       Impact factor: 9.427

2.  A roadmap to the implementation of chromoendoscopy in inflammatory bowel disease colonoscopy surveillance practice.

Authors:  Silvia Sanduleanu; Tonya Kaltenbach; Alan Barkun; Robert P McCabe; Fernando Velayos; Michael F Picco; Loren Laine; Roy Soetikno; Kenneth R McQuaid
Journal:  Gastrointest Endosc       Date:  2015-09-11       Impact factor: 9.427

3.  Inflammatory bowel disease-patients are insufficiently educated about the basic characteristics of their disease and the associated risk of colorectal cancer.

Authors:  Judith E Baars; Corey A Siegel; Adriaan van't Spijker; Tineke Markus; Ernst J Kuipers; C Janneke van der Woude
Journal:  Dig Liver Dis       Date:  2010-05-15       Impact factor: 4.088

4.  SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease.

Authors:  Loren Laine; Tonya Kaltenbach; Alan Barkun; Kenneth R McQuaid; Venkataraman Subramanian; Roy Soetikno
Journal:  Gastroenterology       Date:  2015-03       Impact factor: 22.682

5.  Chromoendoscopy and Dysplasia Surveillance in Inflammatory Bowel Disease: Past, Present, and Future.

Authors:  Steven Naymagon; Thomas A Ullman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-05

Review 6.  Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis.

Authors:  T Thomas; K A Abrams; R J Robinson; J F Mayberry
Journal:  Aliment Pharmacol Ther       Date:  2007-03-15       Impact factor: 8.171

7.  Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.

Authors:  Anthony Lopez; Benjamin Collet-Fenetrier; Arthur Belle; Laurent Peyrin-Biroulet
Journal:  J Dig Dis       Date:  2016-06       Impact factor: 2.325

8.  Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis.

Authors:  Robert D Odze; Francis A Farraye; Jonathan L Hecht; Jason L Hornick
Journal:  Clin Gastroenterol Hepatol       Date:  2004-07       Impact factor: 11.382

9.  Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer.

Authors:  Chang-ho Ryan Choi; Ana Ignjatovic-Wilson; Alan Askari; Gui Han Lee; Janindra Warusavitarne; Morgan Moorghen; Siwan Thomas-Gibson; Brian P Saunders; Matthew D Rutter; Trevor A Graham; Ailsa L Hart
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.